Skip to content

Developing and Testing an Educational Intervention Through Technological Platform to Support Exclusive Breastfeeding

Development of Educational Intervention Through Technological Platform to Support Exclusive Breastfeeding up to Six Months Pilot Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05979571
Enrollment
10
Registered
2023-08-07
Start date
2024-08-15
Completion date
2025-03-15
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Exclusive

Keywords

breastfeeding, mobile health, perinatal care, primary care

Brief summary

Although breastfeeding provides the infant with all the nutrients necessary for its development, it has been observed that in Panama there are low rates of Exclusive Breastfeeding. Educational interventions, that support exclusive breastfeeding, which begin before delivery and continue to the postnatal period, have been shown to be effective. The main objective of the study is the development and testing of an educational intervention through web based platform, to support exclusive breastfeeding up to 6 months. This educational intervention will provide guidance with the help of an audiovisual format, with information and breastfeeding techniques, which mothers can reproduce as many times as necessary. The main objective of the study is the development and testing of an educational intervention through AmiHealth, to support exclusive breastfeeding up to 6 months. A pilot study will be conducted on a non-random convenience sample.

Detailed description

The team leveraged a user-centered design (UCD) approach to design and develop the initial version of the breastfeeding app. An agile development methodology for content and technology development which integrates feedback from all key stakeholders in the development process to refine the app over time, including the content and app.In parallel with the app design, the educational content for the intervention was developed with experts in the field. The contents that will be develop for the breastfeeding module, Data operating system will be used for data management and analytical and projection tools.

Interventions

Breastfeeding knowledge and promotion information will be delivered through the AmiBreastfeed app platform

Sponsors

Sistema Nacional de Investigación Senacyt Panamá
CollaboratorUNKNOWN
Pacifica Salud Hospital
Lead SponsorNETWORK

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. First pregnancy 2. Third trimester

Exclusion criteria

* twin pregnancies fetal defects or newborns with malformations

Design outcomes

Primary

MeasureTime frameDescription
Mobile application rating scale (MARS)two weeksThe quality of the apps will be asses using MARS. This methodology includes 23 evaluation criteria, clustered within 5 domains: (1) Engagement, which assesses the entertainment, customization, and interactivity of the app (feedback, reminders, and notifications); (2) Functionality, which examines the functionality of the app, ease of use, transition between screens, and intuitive design; (3) Esthetics, which assesses graphic design, visual appeal, and stylistic consistency; (4) Information, which evaluates the quality of the content (text, measures, and references), determined by the credibility of the source; and (5) Subjective quality, which determines whether the app could be recommended to people who might benefit from it, if they would be prepared to pay for it, how many times it would be used, and what overall star rating it would be given. Each evaluation criterion was rated from 1 to 5 (1=Inadequate, 2=Poor, 3=Acceptable, 4=Good, 5=Excellent)

Contacts

Primary ContactIsabel Blanco, MD
iblanco@pacificasalud.com2048000
Backup ContactIdalina Cubilla, PhD
idacubilla@gmail.com2048000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026